Well we can’t yet.
Merck (MRK.N) has announced their results in a new pill that has shown to prevent death from COVID-19. This fantastic news for all of us.
Merck is seeking emergency authorization for use worldwide.
At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died
Merck Plans to Seek Emergency Use Authorization in the U.S. as Soon as Possible and to Submit Applications to Regulatory Agencies Worldwide
If Authorized, Molnupiravir Could be the First Oral Antiviral Medicine for COVID-19
For the full report: Go here.